Skip to content
Home
About
Consulting
In Office Infection Control Consulting
eLearning
Online Consulting
Education Programs
Skype Consulting
Shop
All Products
eLearning Classes
Training Programs – DVD
Training Manuals
Newsletters
Blog
Germ Catcher Blog
Infection Control
CDC News
EID Journal
Events
Log In
Contact
Menu
Home
About
Consulting
In Office Infection Control Consulting
eLearning
Online Consulting
Education Programs
Skype Consulting
Shop
All Products
eLearning Classes
Training Programs – DVD
Training Manuals
Newsletters
Blog
Germ Catcher Blog
Infection Control
CDC News
EID Journal
Events
Log In
Contact
$
0.00
0
Cart
Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
By
Emerging Infectious Diseases Journal
March 30, 2014
9:00 pm
T. Eyckmans et al.
T. Eyckmans et al.
Emerging Infectious Diseases Journal
Facebook
Twitter
LinkedIn
Pinterest
Emerging Infectious Diseases Journal
All Posts »
Prev
Previous
News Scan for Mar 28, 2014
Next
H7N9 sickens 3 more in 3 Chinese provinces
Next
